CRG Experience and History

Our Experience

    • A Randomized, Double-Blind, Placebo-Controlled Parallel Group Phase III Study of the Efficacy, Tolerability, and Safety of (the study drug) in the Treatment of Pain Associated with Grade 1 or Grade 2 Ankle Sprain or Strain.

 

    • A Phase III Open-Label, Single Arm Study to Assess the Safety of (the study drug) for Minimal-to-Moderate Sedation in Patients Undergoing Minor Surgical Procedures.

 

    • A Phase III, Open-Label Period Followed by Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of (the study drug) Compared to Placebo in Subjects with Chronic Low Back Pain.

 

    • A Phase III, Randomized, Multicenter, Double-Blind Study Comparing the Analgesic Efficacy of (the study drug) to Placebo in Subjects with Osteoarthritis.

 

    • A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two Week Study to Assess the Safety and Efficacy of (the study drug) in Subjects with Pain from Moderate Lateral Epicondylitis.

 

    • A Randomized, Double-Blind, Placebo-Controlled, Multi-center Phase III Study to Evaluate the Long-Term Safety of (the study drug) for 12 Months for the treatment of Opioid-Induced Bowel Dysfunction in Adults taking Opioid Therapy for Persistent Non-Cancer Pain.

 

    • An Open Label Safety Study with Intermittent Use of (the study drug) in Subjects with Lower Back Pain, Pain from Osteoarthritis of the Knee, Shoulder Pain, or Lateral Epicondylitis Pain.

 

    • An Open Label Study Evaluating the Safety and Tolerability of Long Term Administration of (the study drug) in Subjects with Moderate to Severe Chronic Non-Malignant Pain.

 

    • A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of (the study drug) versus Midazolam HCl for Sedation in Patients Undergoing Minor Surgical Procedures.

 

    • A Randomized, Multi-Center, Double-Blind Study Comparing the Analgesic Efficacy of (the study drug) Extended Release and Placebo in Subjects with Osteoarthritis.

 

    • A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Trial of (the study drug) in Subjects Undergoing Bunionectomy with First Metatarsal Osteotomy Surgery.

 

    • A Randomized, Double-Blind, Placebo-controlled Study Comparing the Analgesic Activity of (the study drug) Extended Release and Placebo in Subjects with Pain Following Bunionectomy Surgery.

 

    • A Multi-Center, Single Dose, Double-blind, Placebo-Controlled, Randomized, Pilot Study To Investigate the Assay Sensitivity of Single Digit Hammertoe Surgery As A Model For The Study Of Analgesic Drugs In Acute Pain.

 

    • A Randomized Multiple Dose Assessment of the Safety of the (the study drug) Ready to Use (RTU) Formulation Compared to Parecoxib Sodium Lyophilized Preparation in Patients in Pain Following a Bunionectomy.

 

    • A Randomized, Double-Blind, Placebo Controlled, Multiple Dose Assessment of the Analgesic Efficacy of the Dosing Regimen of (the study drug) Compared to Placebo Patients in Pain Following a Bunionectomy.

 

    • A Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of (the study drug) Compared to Placebo in Patients for Treatment of Post-Surgical Pain from Bunionectomy Surgery.

 

    • A Randomized, Double-Blind, Parallel-Group Study Assessing the Analgesic Efficacy and Safety of Four Dose Levels of (the study drug) compared to Ibuprofen 400 mg, Morphine 60 mg and Placebo in Patients with acute Pain Following Orthopedic Surgery (Bunionectomy).

 

    • A randomized double-blind, Placebo and active comparator controlled parallel group multi-center study of (the study drug) and naprelan in the treatment of post-Bunionectomy surgery pain.

 

    • A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study Assessing the Analgesic Efficacy and Safety of Five Dose Levels of (the study drug) compared to Morphine 60mg, Ibuprofen 400 mg,and Placebo in patients following Orthopedic Surgery (Bunionectomy).

 

    • Analgesic Efficacy of Single doses of (the study drug) and Multiple Doses of (the study drug) Compared with Single and Multiple doses of Naproxen Sodium 500mg or placebo in Patients with Pain from Outpatient Orthopedic surgery (Bunionectomy).

 

    • Comparative Analgesic Efficacy of Single and Multiple Doses of (the study drug), Naproxen Sodium 550mg, or Placebo in Pain Following Outpatient Orthopedic surgery (Bunionectomy).

 

  • A Double Blind Placebo and Active-Controlled Comparison of the Analgesic Activity of (the study drug) and Placebo in Post Bunionectomy Surgical Patients.

Our History

History of CRG

Our Mission

<p>I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.</p>

Chesapeake Research Group, LLC is a clinical trial investigative site dedicated to supporting our clients in the development of products by conducting rigorous and efficient clinical drug/ device trials.

Our staff is committed to producing and submitting clean and precise data in a timely fashion. We are a multi-specialty site that has established affiliations with primary care and other specialty groups.